COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02609763
Recruitment Status : Completed
First Posted : November 20, 2015
Last Update Posted : December 2, 2015
Information provided by (Responsible Party):
Topokine Therapeutics, Inc.

Brief Summary:
This observational study will test the inter-rater and test-retest reliability of the LESS scale in a live context.

Condition or disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Live Validation of the Lower Eyelid Steatoblepharon Severity (LESS) Scale
Study Start Date : November 2015
Actual Primary Completion Date : November 2015
Actual Study Completion Date : November 2015

Primary Outcome Measures :
  1. LESS score (Clinician-Reported) [ Time Frame: Eyelids will be assessed on one day only (cross-sectional study) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   25 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Eligible adults with varying degrees of lower eyelid steatoblepharon

Inclusion Criteria:

  • Must provide informed consent

Exclusion Criteria:

  • Unable or unwilling to complete study procedures

Layout table for additonal information
Responsible Party: Topokine Therapeutics, Inc. Identifier: NCT02609763    
Other Study ID Numbers: TPK-SCALE-03
First Posted: November 20, 2015    Key Record Dates
Last Update Posted: December 2, 2015
Last Verified: November 2015